
Introduction. Access to safe, effective, and affordable medicines remains a key component of healthcare systems and an important determinant of public health and national security. Recent global and national challenges, including the COVID-19 pandemic and the ongoing war in Ukraine, have exposed vulnerabilities in pharmaceutical supply chains and emphasized the importance of resilient healthcare infrastructure. This article examines the role and potential of hospital pharmacies as an essential component of the pharmaceutical supply system within healthcare facilities. Methods. Comparative analysis of the regulatory and professional literature governing hospital pharmacy, examining the national legal framework of Ukraine alongside guidance documents from the European Association of Hospital Pharmacists (EAHP), the American Society of Health-System Pharmacists (ASHP), and the European Commission. Polish Pharmaceutical Law was selected and analyzed as a case example of practical EU implementation. Identified sources, accessed between February and May 2026, were compared descriptively with the Ukrainian regulatory situation to identify gaps and reform directions. Results. The study analyzes the regulatory framework governing hospital pharmacies in Ukraine and compares it with international approaches, particularly those adopted in the European Union and the United States. Although the concepts of hospital pharmacy exist in Ukrainian legislation, in practice such structural units have largely disappeared from healthcare facilities. At the same time, international experience demonstrates that hospital pharmacies play a crucial role in procurement, compounding, storage, distribution, and monitoring of medicines, as well as in ensuring rational pharmacotherapy and drug safety. The analysis highlights the economic and organizational advantages of restoring hospital pharmacy units, including improved control over drug distribution, reduction of treatment costs through pharmacy compounding and bulk procurement of active pharmaceutical ingredients, implementation of unit-dose systems, and improved drug traceability. In addition, hospital pharmacies can serve as centers for professional education, training and clinical trials. The development of regulatory mechanisms supporting pharmacy compounding, bulk procurement of pharmaceutical substances, and digitalization of medication management processes is considered a promising direction for healthcare system reform. Conclusions. Restoring hospital pharmacies as structural units of healthcare facilities, together with regulatory support for pharmacy compounding, bulk procurement, and digitalization of medication management, can strengthen the resilience and efficiency of the pharmaceutical supply system in Ukraine and restore the practical, educational, and research functions of hospital pharmacy.
Background. High-risk percutaneous coronary interventions (high-risk PCI) in patients with complex coronary artery disease and reduced left ventricular systolic function are associated with a substantial risk of hemodynamic instability and periprocedural complications. Mechanical circulatory support may improve the safety of these procedures by maintaining adequate systemic perfusion during technically demanding stages of the intervention. Objective: To evaluate the safety and results of prophylactic veno-arterial extracorporeal membrane oxygenation (V-A ECMO) during high-risk PCI in patients with coronary artery disease and to identify factors associated with in-hospital mortality. Methods. A single-center retrospective observational study was conducted, including consecutive patients who underwent elective high-risk PCI with prophylactic V-A ECMO support between 2019 and 2025. The primary endpoint was in-hospital mortality. We used logistic regression to identify predictors of mortality. Results. A total of 43 patients were included in the analysis (mean age 66.1 ± 8.9 years; 74.4% male). The mean left ventricular ejection fraction was 31.9 ± 6.8%, and the mean SYNTAX score was 32.4 ± 6.8. Successful revascularization was achieved in 90.7% of cases, and ECMO weaning at the end of the procedure was possible in 88.4% of patients. In-hospital mortality was 14.0%. Major bleeding occurred in 20.9% of patients, vascular complications in 11.6%, and acute kidney injury in 23.3%. In multivariable analysis, the maximum vasoactive-inotropic score (VIS) was identified as an independent predictor of in-hospital mortality (OR 1.10; 95% CI 1.01–1.21; p = 0.041). Conclusions. Prophylactic V-A ECMO enabled elective high-risk PCI in a highly selected cohort with complex coronary anatomy and impaired left ventricular function. However, the substantial in-hospital mortality and complication rates, together with the retrospective design and absence of a control group, preclude conclusions regarding clinical effectiveness. Prospective controlled studies are required to determine whether prophylactic V-A ECMO improves outcomes compared with unsupported PCI or other mechanical circulatory support strategies.
Реферат Доступ до безпечних, ефективних та доступних ліків залишається ключовим компонентом систем охорони здоров'я та важливим фактором, що визначає стан громадського здоров'я та національної безпеки. Нещодавні глобальні та національні виклики, включаючи пандемію COVID-19 та війну, що триває в Україні, виявили слабкі ланки у фармацевтичних ланцюгах постачання, а також підкреслили важливість стійкої інфраструктури охорони здоров'я. У цій статті розглядається роль та потенціал лікарняних аптек як важливого компонента системи фармацевтичного постачання в закладах охорони здоров'я. У дослідженні аналізується нормативно-правова база, що регулює діяльність лікарняних аптек в Україні, та порівнюється з міжнародними підходами, зокрема тими, що прийняті в Європейському Союзі та Сполучених Штатах. Хоча концепція лікарняної аптеки існує в українському законодавстві, на практиці такі структурні підрозділи значною мірою зникли з закладів охорони здоров'я. Водночас міжнародний досвід показує, що лікарняні аптеки відіграють вирішальну роль у закупівлі, виготовленні ліків, зберіганні, розподілі та моніторингу лікарських засобів, а також у забезпеченні раціональної фармакотерапії та безпеки ліків. В аналізі висвітлюються економічні та організаційні переваги відновлення лікарняних аптечних підрозділів, включаючи покращений контроль за розподілом ліків, зниження витрат на лікування завдяки виготовленню ліків в умовах аптек та оптовим закупівлям активних фармацевтичних інгредієнтів, впровадження систем одиничних доз (unit dose) та покращення системи відстеження лікарських засобів в закладі охорони здоров’я. Крім того, лікарняні аптеки можуть слугувати центрами професійної освіти, навчання та клінічних випробувань. Розробка регуляторних механізмів для аптечного виготовлення лікарських засобів, оптових закупівель активних субстанцій та цифровізації процесів обліку лікарських засобів в лікарнях, є перспективним напрямком реформування системи охорони здоров'я. Abstract Access to safe, effective, and affordable medicines remains a key component of healthcare systems and an important determinant of public health and national security. Recent global and national challenges, including the COVID-19 pandemic and the ongoing war in Ukraine, have exposed vulnerabilities in pharmaceutical supply chains while also emphasizing the importance of resilient healthcare infrastructure. This article examines the role and potential of hospital pharmacies as an essential component of the pharmaceutical supply system within healthcare facilities. The study analyzes the regulatory framework governing hospital pharmacies in Ukraine and compares it with the international approaches, particularly those adopted in the European Union and the United States. Although the concepts of hospital pharmacy exist in Ukrainian legislation, in practice such structural units have largely disappeared from healthcare facilities. At the same time, international experience demonstrates that hospital pharmacies play a crucial role in procurement, compounding, storage, distribution, and monitoring of medicines, as well as in ensuring rational pharmacotherapy and drug safety. The analysis highlights the economic and organizational advantages of restoring hospital pharmacy units, including improved control over drug distribution, reduction of treatment costs through pharmacy compounding and bulk procurement of active pharmaceutical ingredients, implementation of unit-dose systems, and improved drug traceability. In addition, hospital pharmacies can serve as centers for professional education, training and clinical trials. The development of regulatory mechanisms supporting pharmacy compounding, bulk procurement of pharmaceutical substances, and digitalization of medication management processes is considered a promising direction for healthcare system reform.
The 21st-century post-pandemic health crisis is driven by the rising prevalence of chronic diseases globally. These diseases span several domains, and most of them can be predicted or prevented. Today, stress resilience is defined as the ability to adapt to novel conditions, environments, and stressors through multiple mechanisms and to recover from stressors. It can be an effective tool for preventing chronic diseases. This narrative-integrative review pursues a single overarching question: how stress resilience has evolved as a scientific concept over the past 9 decades, and to what extent it is currently represented in mainstream medical and health sciences textbooks. We address this question through four complementary components: (1) a historical synthesis, (2) a structured textbook survey, (3) a curricular position argument, and (4) a description of the iSSS model as a practical example. The article traces the 90-year evolution of stress research, including the most recent concept of stress resilience, from Hans Selye’s pioneering 1936 publication on the “general adaptation syndrome” in Nature. We review here the subsequent developments and current representation in medical and healthcare textbooks used by future medical professionals to prepare for clinical settings. The intellectual trajectory of stress response research has advanced through numerous mechanistic, molecular, and cellular discoveries, including contributions from Nobel laureates Roger Guillemin (for the discovery of “peptide hormone production of the brain,” i.e., two of the hypothalamic releasing factors in 1977), former PhD student of Selye, and Eric Kandel (work on memory, 2000), who have elucidated the neurobiological mechanisms underlying post-traumatic stress disorders and other mental illnesses. Over the past nine decades, explanations of stress response have evolved from structural-functional descriptions to molecular mechanisms and multisystem levels (e.g., brain-hypothalamic-pituitary-adrenal (HPA)-gut-fat, brain-HPA-fat-immunity) and systemic levels (e.g., mind-body integration). This evolution helps clarify the etiopathogenetic effects of chronic stress on metabolic dysregulation, the development of chronic relapsing diseases, and/or accelerated aging. Despite the increased prevalence and mortality of chronic diseases in the 21st century and the significant time physicians now dedicate to managing metabolic dysregulation and chronic diseases, stress resilience remains inadequately addressed in medical education. Drawing on twelve years of experience with the international Summer Schools on Stress (iSSS) and a global network of health educators, the article outlines the current state of the field, necessary curricular reforms, and how the iSSS model offers a replicable, practical, and cost-effective approach to educating future medical professionals about stress resilience and targeted interventions. Moving from a “sick” health system to a healthcare system by shaping the education of medical and health allies through expanded curricula on stress resilience across the pre-clinical and clinical years will have a strong impact on patient care, with a focus on personal responsibility for health.
Clinical immunology, allergology, and rheumatology play a vital role in modern medicine, combining fundamental scientific research with practical healthcare. These fields study the mechanisms underlying the development of immunopathological reactions, their clinical manifestations, and methods of diagnosis, prevention, and treatment. Over the past decades, the prevalence of immunopathology has been steadily increasing, making clinical immunology and allergology among the key fields in both practical medicine and the biomedical sciences. Current challenges, recent achievements, and future directions of clinical immunology, allergology, and rheumatology in Ukraine were discussed by Ukrainian scientists and clinicians, as well as international colleagues, at the annual scientific and practical conference with international participation, “Christmas Readings in Lviv. A Multidisciplinary Approach in Medicine: Current Developments and Challenges in Immunology, Allergology, and Rheumatology,” held on November 26–27, 2025. Traditionally, the conference was organized by the Danylo Halytsky Lviv National Medical University and the Medical Commission of the Shevchenko Scientific Society. The interdisciplinary scientific and practical conference brought together a large community of experts, involving more than 100 leading speakers. The event’s strong international focus was ensured by foreign experts who presented cutting-edge experience and innovative clinical developments. The international speakers represented 11 countries, including leading research centers in the United States, Canada, the United Kingdom, Germany, Poland, Denmark, Ireland, Spain, Greece, as well as Brazil and Argentina. The forum’s program generated significant interest among the medical community, attracting approximately 500 attendees from various specialties.